| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
-
Oct 28, 2025Virtual Press Office and PR Newswire: General Trade show news
CWSS-SCM and NCWSS will provide ample weed science research presentations and learning opportunities at their November and December meetings WESTMINSTER, Colo., Oct. 28, 2025 /PRNewswire/ -- Two...
-
Oct 28, 2025Virtual Press Office and PR Newswire: General Trade show news
HUMAIN, a global AI company under the Public Investment Fund (PIF) building end-to-end AI stack capabilities, today announced the launch of HUMAIN ONE, its proprietary agentic AI operating system,...
-
Oct 28, 2025Virtual Press Office and PR Newswire: General Trade show news
Anomaly detection use case will be demonstrated live with partner Q-KON at AfricaCom 2025 HERNDON, Va., Oct. 28, 2025 /PRNewswire/ -- ST Engineering iDirect, a global leader in satellite...
-
Oct 28, 2025Virtual Press Office and PR Newswire: General Trade show news
Reqorsa® Gene Therapy is a Potential Treatment for ALK-EML4 Positive Translocated Non-Small Cell Lung Cancer Combining REQORSA with Alectinib Further Increased Apoptosis and Improved Treatment...
-
Oct 28, 2025Virtual Press Office and PR Newswire: General Trade show news
Results presented at the 17th World Stroke Congress (WSC 2025) LT3001(Odatroltide)-202 phase 2b study met primary endpoint. No symptomatic intracranial hemorrhage occurred. Data suggest that...
